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Abstract. The membrane phospholipid organisation in the red cells of humans suffering 
from chronic myeloid leukaemia has been analysed using the amino-group labelling reagent 
trinitrobenzenesulphonic acid and the fluid-sensing fluorophore, Merocyanine 540. Unlike 
the normal human erythrocytes, trinitrobenzenesulphonic acid in intact chronic myeloid 
leukaemia erythrocytes modified about 30% phosphatidylserine, under controlled 
conditions. Also, the chronic myeloid laukaemia red cells, but not the normal cells, were 
found to bind the fluorescent dye Merocyanine 540. These results demonstrate that loss of 
the transmembrane phospholipid asymmetry in chronic myeloid leukaemia erythrocytes is 
accompanied by an enhancement in the outer surface fluidity and, therefore, suggest that the 
red cells membrane phase-state asymmetry originates probably from the asymmetric arra-
ngements of phospholipids across the membrane bilayer. 
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Introduction 
 
Chronic myeloid leukaemia (CML) is a clonal disorder common to granulocyte, 
platelet and erythrocyte precursors (Champlin and Golde, 1985; Gale and Cannani, 
1985). Our recent studies have shown that the CML erythrocyte spectrin becomes 
abnormal due to crosslinking of its two subunits via disulphide bonds (Kumar and 
Gupta, 1983). This abnormality in these cells has been found to be associated with 
the presence of substantial amounts of Phosphatidylserine (PS) in the outer surface 
of the membrane bilayer (Kumar and Gupta, 1983). We now report that the amino- 
group labelling reagent, trinitrobenzenesulphonic acjd (TNBS),- can readily modify 
about 30% PS in the intact CML erythrocytes. In addition, we show that the fluid- 
sensing probe, Merocyanine 540 (Mc 540), binds the CML cells but not the normal 
erythrocytes. These results indicate that the membrane skeletal defects in CML ery-
throcytes are associated not only with loss of the transmembrane phospholipid 
asymmetry but also lead to an increase in the outer monolayer fluidity. 
 
Materials and methods 
 
All the chemicals and reagents used in this study were of the highest purity available. 
TNBS, bovine serum albumin (fatty acid free) and 5,5'-dithiobis (2-nitrobenzoic acid) 
(DTNB) were purchased from Sigma Chemical. Company, St. Louis, Missouri, USA. 
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Mc 540 was a gift from Dr. Rolf D. Walter, Bernhard Nocht Institute, Humburg, 
Federal Republic of Germany. Fetal calf serum was from Difco, USA. 
Blood from leukaemic male patients (aged 35-50 years) and from healthy adult 
donors was obtained from King George's Medical College, Lucknow, and drawn by 
venepuncture into heparinized glass tubes. All the patients studied here were esta 
blished cases of CML as shown by their haematological and clinical analysis. Ery-
throcytes from whole blood were isolated as described earlier (Kumar and Gupta, 
1983). 
 
 
Labelling of erythrocytes with TNBS 
 
Erythrocytes were labelled with TNBS essentially according to the method of 
Gordeski et al. (1975). Incubations were done for varying periods of time (3,6 and 
9 h) at 10°, 20° and 30°C. At 20°C, incubations were carried out both in the presence 
and absence of an anion channel protein inhibitor, DTNB (Reithmeier, 1983; Toon et 
al., 1985). Cells from incubation mixtures were harvested by centrifugation and 
washed several times with saline (pH 7·4). Lipids from washed cells were extracted 
and chromatographed on silica gel G-60 thin-layer chromatography plates according 
to the published procedures (Kumar and Gupta, 1983) and the percentage of TNBS 
labelling was determined as described earlier (Gupta and Mishra, 1981). 
 
Binding of erythrocytes with Mc 540 
 
Studies on binding of Mc 540 to both normal human and CML erythrocytes were 
carried out according to Schlegel et al. (1980). The optimum conditions of dye con-
centrations, duration of incubation and serum concentration were established so that 
no fluorescence was observed in the normal cells due to non-specific adherence of the 
dye. Using these conditions, the binding of Mc 540 to CML erythrocytes was carried 
out and compared. Fluorescence microscopy was performed with a Zeiss microscope 
using epillumination with green excitation filter BP 546/12 and barrier filter LP 590. 
Erythrocytes were photographed using ASA 400 Kodak VR film. 
 
Results 
 
Erythrocyte aminophospholipid labelling with TNBS 
 
The amino-group labelling reagent, TNBS, has widely been used as an external 
membrane probe to determine the transbilayer amino-phospholipid distributions in 
the membranes of various types of cells (reviewed by Etemadi, 1980; Roelofsen, 
1982). However, conditions need to be optimised for using this reagent in the studies 
of phospholipid distribution across the erythrocyte membrane, as it is known that 
TNBS penetrates into the human red cells upon prolonged incubations and/or at 
temperatures > 20°C (Gordesky et al., 1975; Haest et al., 1981). Therefore, normal as 
well as CML erythrocytes were treated with the reagent at various temperatures for 
varying periods of time. Table 1 shows that at 10° and 20°C, TNBS modified only 
PE in the normal cells and both PE and PS in the CML cells; although, labelling at 
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Table 1. Labelling of erythrocytes with TNBS. 
Values are mean of 6-8 determinations ± S.D. 
 
10°C was a trifle inhibited as the amount of phosphatidylethanolamine (PE) labeled 
in the normal cells was less than that reported to be present in the outer monolayer 
(Gordesky et al., 1975). However, raising the incubation temperature to 30°C 
resulted in complete lysis of CML erythrocytes and in labelling of both PE and PS in 
the normal cells. Moreover, even at 20°C the amounts of labelled aminophospho- 
lipids increased significantly with time in case of CML erythrocytes. These results 
indicate that TNBS readily penetrates into both normal and CML erythrocytes at 
30°C and in the CML cells only upon prolonged incubation at 20oC. The labelling at 
20°C of CML cells could not be continued to saturation as incubation of these cells 
beyond 9 h, resulted in heavy lysis. 
Penetration of TNBS into red cells is known to be inhibited upon blocking the red 
cells anion transfer system by an appropriate anion channel protein inhibitor (Haest 
et al., 1981). Therefore, we treated the red cells with TNBS at 20°C in the presence of 
an anion channel protein inhibitor, DTNB (Reithmeier, 1983; Toon et al., 1985). 
Table 2 shows that under these conditions about 19% PE was modified in the 
normal cells whereas in CML erythrocytes, about 26% PE and 30% PS were 
labelled. These amounts of labelled amino-phospholipids are comparable to those 
 
Table 2. Labelling of erythrocytes with TNBS in the presence 
of DTNB 
Incubation were done at 20oC for 9h. 
Values are mean of 4 determinations ± S.D. 
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labelled by TNBS at 10°C or 20°C (3 h) in the absence of DTNB. From these 
findings, it may be concluded that the typical transmembrane phospholipids 
asymmetry in erythrocytes (Schwartz et al., 1985) is lost during CML. This is quite 
consistent with the earlier studies (Kumar and Gupta, 1983). 
 
Mc 540 binding to erythrocytes 
 
Mc 540 is a negatively charged fluorescent dye, having the unique characteristic 
feature to show enhanced fluorescence on intercalation with the hydrophobic dom 
ain of the bilayer, and it binds preferentially to relatively disordered or fluid domains 
in the outer leaflet of the membrane bilayer in intact cells (Williamson et al., 1982). 
The dye has a low affinity for the normal red cell membrane, and even this affinity is 
abolished by the addition of a competing serum at a concentration of 5%. For this 
purpose, autologus plasma, AB serum, fetal calf serum or even bovine serum albumin 
can be used. Of the various sera tested, AB serum was found to give the best results. The 
optimum results were obtained by using 5% AB serum and a dye concentration 
of 20 µg/ml cell suspension. Incubation of 105–106 red cells/ml for 10 min at 37°C 
was adequate. Under these conditions, 40-60% CML erythrocytes were stained with 
the dye whereas the normal red cells completely failed to fluoresce after the Mc 540 
treatment (figure 1). These results strongly indicate that fluidity of the outer leaflet of 
the erythrocyte membrane bilayer is enhanced in CML. 
 
 
Discussion 
 
Erythrocyte membrane phospholipids are asymmetrically distributed across the 
membrane bilayer (reviewed by Schwartz et al., 1985). Phosphatidylcholine and 
sphingomyelin are localized mainly in the outer monolayer whereas PE and PS are 
present almost exclusively in the inner monolayer. This typical transmembrane phos-
pholipid asymmetry was absent in CML erythrocytes, since considerably larger 
amounts of aminophospholipids were found to be located in the external monolayer 
of these cells, as compared with the normal human erythrocytes. In the normal cells, 
about 19% PE and 0% PS were labelled by TNBS whereas in the CML cells, this 
reagent modified about 26% PE and 30% PS. These amounts of the labelled amino-
phospholipids should represent the external phospholipids, as similar amounts of 
these lipids have earlier been shown to be accessible to phospholipase A2 in the 
intact CML erythrocytes (Kumar and Gupta, 1983). 
Human red cell membrane choline-phospholipids are known to be more saturated 
than the aminophospholipids (Williams et al., 1966). Therefore, movements of PE 
and PS from the inner to the outer monolayer should lead to an increase in the outer 
surface fluidity. This is quite consistent with the present observation that Mc 540 
readily binds to the CML erythrocytes but fails to stain the normal red cells. 
This study demonstrates that during CML loss of the transmembrane phospho 
lipid asymmetry in erythrocytes is associated with an increase in the outer monolayer 
fluidity. These membrane changes in the cells are probably induced by the structural 
defects in the membrane skeletal proteins (Kumar and Gupta, 1983), as associations 
of these proteins with the membrane bilayer seem to stabilize the membrane phos 
pholipid asymmetry in the red cells (Haest, 1982). Also, our results corroborate the
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Figure 1. Staining of human erythrocytes with Mc 540. All the cells were photographed at 
the same magnification and exposure time of 30 s. A, Normal erythrocytes; Β and C, CM 
erythrocytes. Note that the membranes of CML erythrocytes fluoresce after Mc 540 staining 
but under identical conditions, the normal red cells do not show any fluorescence. 
 
 
earlier studies which showed that differential fluidities across the erythrocyte 
membrane are due to asymmetric transbilayer distributions of the membrane phos-
pholipids (Williamson et al., 1982). 
Further, it has earlier been suggested that alterations in the membrane phospho 
lipid asymmetry leads to several pathological disorders (Schwartz et al., 1985). Severe 
anaemia in CML patients could be due to the externalisation of PS, as it would 
accelerate the distruction of the CML red cells by the macrophages (Schroit et al., 
1985). 
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